Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Express Scripts
McKinsey
Dow
AstraZeneca

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Human secretin

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Human secretin: Sponsors, patents, clinical trial progress

Human secretin is an investigational drug.

There have been 17 clinical trials for Human secretin. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2017.

The most common disease conditions in clinical trials are Pancreatitis, Pancreatic Neoplasms, and Pancreatitis, Chronic. The leading clinical trial sponsors are Repligen Corporation, ChiRhoClin, Inc., and Massachusetts General Hospital.

There are six US patents protecting this investigational drug and forty-nine international patents.

Recent Clinical Trials for Human secretin
TitleSponsorPhase
Secretin for Acute PancreatitisDartmouth-Hitchcock Medical CenterPhase 2
Secretin for Acute PancreatitisChiRhoClin, Inc.Phase 2
Effect of Secretin in Functional Dyspepsia and Healthy SubjectsMayo ClinicPhase 1/Phase 2

See all Human secretin clinical trials

Clinical Trial Summary for Human secretin

Top disease conditions for Human secretin
Top clinical trial sponsors for Human secretin

See all Human secretin clinical trials

US Patents for Human secretin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Human secretin   Start Trial Method for use of magnetic resonance imaging to image pancreas using secretin Wayne State University (Detroit, MI)   Start Trial
Human secretin   Start Trial Method for assisting in differential diagnosis and treatment of autistic syndromes Repligen Corporation (Waltham, MA)   Start Trial
Human secretin   Start Trial Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) Pharmagene Laboratories Ltd. (Hertfordshire, GB)   Start Trial
Human secretin   Start Trial Methods for treatment of acute pancreatitis ChiRhoClin, Inc. (Burtonsville, MD)   Start Trial
Human secretin   Start Trial Methods for preventing post endoscopic retrograde cholangiopancreatography pancreatitis   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Human secretin

Drugname Country Document Number Estimated Expiration Related US Patent
Human secretin Austria 295176 2017-05-19   Start Trial
Human secretin Austria 322283 2017-05-19   Start Trial
Human secretin Australia 4432299 2017-05-19   Start Trial
Human secretin Australia 748147 2017-05-19   Start Trial
Human secretin Australia 7688598 2017-05-19   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Colorcon
Harvard Business School
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.